Search by Drug Name or NDC
NDC 00575-6200-30 Proglycem 50 mg/mL Details
Proglycem 50 mg/mL
Proglycem is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is DIAZOXIDE.
Product Information
NDC | 00575-6200 |
---|---|
Product ID | 0575-6200_feeca3aa-0bb3-4873-8887-e1c53accf956 |
Associated GPIs | 27300020001810 |
GCN Sequence Number | 000298 |
GCN Sequence Number Description | diazoxide ORAL SUSP 50 MG/ML ORAL |
HIC3 | M4G |
HIC3 Description | AGENTS TO TREAT HYPOGLYCEMIA (HYPERGLYCEMICS) |
GCN | 01280 |
HICL Sequence Number | 000092 |
HICL Sequence Number Description | DIAZOXIDE |
Brand/Generic | Brand |
Proprietary Name | Proglycem |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | diazoxide |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | SUSPENSION |
Route | ORAL |
Active Ingredient Strength | 50 |
Active Ingredient Units | mg/mL |
Substance Name | DIAZOXIDE |
Labeler Name | Teva Pharmaceuticals USA, Inc. |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA017453 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00575-6200-30 (00575620030)
NDC Package Code | 0575-6200-30 |
---|---|
Billing NDC | 00575620030 |
Package | 1 BOTTLE, DROPPER in 1 BOX (0575-6200-30) / 30 mL in 1 BOTTLE, DROPPER |
Marketing Start Date | 1990-09-30 |
NDC Exclude Flag | N |
Pricing Information | N/A |